×
+ All Categories
Log in
English
Français
Español
Deutsch
Report -
Farmaci Antidiabetici e Rischio Cardio-Nefro- Vascolare...Renal Outcomes with Empagliflozin 7 EMPA-REG RENAL (N=7020) *Doubling of SCr + eGFR ≤45 mL/min/1.73 m 2, initiation of renal
Name
Email
Select
Select
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Message
Please pass captcha verification before submit form